170 related articles for article (PubMed ID: 29969563)
1. Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor.
Canfarotta F; Lezina L; Guerreiro A; Czulak J; Petukhov A; Daks A; Smolinska-Kempisty K; Poma A; Piletsky S; Barlev NA
Nano Lett; 2018 Aug; 18(8):4641-4646. PubMed ID: 29969563
[TBL] [Abstract][Full Text] [Related]
2. Epitope Molecularly Imprinted Polymer Nanoparticles for Chemo-/Photodynamic Synergistic Cancer Therapy Guided by Targeted Fluorescence Imaging.
Peng H; Qin YT; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Mar; 12(11):13360-13370. PubMed ID: 32101405
[TBL] [Abstract][Full Text] [Related]
3. Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes.
Piletsky SS; Baidyuk E; Piletska EV; Lezina L; Shevchenko K; Jones DJL; Cao TH; Singh R; Spivey AC; Aboagye EO; Piletsky SA; Barlev NA
Nano Lett; 2023 Nov; 23(21):9677-9682. PubMed ID: 37902816
[TBL] [Abstract][Full Text] [Related]
4. Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor.
Zhang Y; Li S; Ma XT; He XW; Li WY; Zhang YK
Mikrochim Acta; 2020 Mar; 187(4):228. PubMed ID: 32170469
[TBL] [Abstract][Full Text] [Related]
5. Highly Effective Drug Delivery and Cell Imaging Using Fluorescent Double-Imprinted Nanoparticles by Targeting Recognition of the Epitope of Membrane Protein.
Qin YT; Peng H; He XW; Li WY; Zhang YK
Anal Chem; 2019 Oct; 91(20):12696-12703. PubMed ID: 31532634
[TBL] [Abstract][Full Text] [Related]
6. Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.
Milane L; Duan Z; Amiji M
Mol Pharm; 2011 Feb; 8(1):185-203. PubMed ID: 20942457
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
Qin YT; Feng YS; Ma YJ; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24585-24598. PubMed ID: 32390415
[TBL] [Abstract][Full Text] [Related]
8. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
9. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
10. Preparation and study of tramadol imprinted micro-and nanoparticles by precipitation polymerization: microwave irradiation and conventional heating method.
Seifi M; Hassanpour Moghadam M; Hadizadeh F; Ali-Asgari S; Aboli J; Mohajeri SA
Int J Pharm; 2014 Aug; 471(1-2):37-44. PubMed ID: 24792981
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y Y1 receptors mediate [corrected] targeted delivery of anticancer drug with encapsulated nanoparticles to breast cancer cells with high selectivity and its potential for breast cancer therapy.
Li J; Shen Z; Ma X; Ren W; Xiang L; Gong A; Xia T; Guo J; Wu A
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5574-82. PubMed ID: 25695533
[TBL] [Abstract][Full Text] [Related]
13. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
[TBL] [Abstract][Full Text] [Related]
14. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
15. Receptor and Microenvironment Dual-Recognizable Nanogel for Targeted Chemotherapy of Highly Metastatic Malignancy.
Chen J; Ding J; Xu W; Sun T; Xiao H; Zhuang X; Chen X
Nano Lett; 2017 Jul; 17(7):4526-4533. PubMed ID: 28644032
[TBL] [Abstract][Full Text] [Related]
16. Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.
Talaei F; Azizi E; Dinarvand R; Atyabi F
Int J Nanomedicine; 2011; 6():1963-75. PubMed ID: 21976973
[TBL] [Abstract][Full Text] [Related]
17. Distinction Between Active and Passive Targeting of Nanoparticles Dictate Their Overall Therapeutic Efficacy.
Clemons TD; Singh R; Sorolla A; Chaudhari N; Hubbard A; Iyer KS
Langmuir; 2018 Dec; 34(50):15343-15349. PubMed ID: 30441895
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
19. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HER2-Positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway with HER2-Glycan-Imprinted Nanoparticles.
Dong Y; Li W; Gu Z; Xing R; Ma Y; Zhang Q; Liu Z
Angew Chem Int Ed Engl; 2019 Jul; 58(31):10621-10625. PubMed ID: 31166063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
